Aceprometazine
![]() | |
Systematic (IUPAC) name | |
---|---|
1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Oral |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal and fecal |
Identifiers | |
CAS Number |
13461-01-3 ![]() |
ATC code | none |
PubChem | CID 26035 |
DrugBank |
DB01615 ![]() |
ChemSpider |
24249 ![]() |
UNII |
984N9YTM4Y ![]() |
ChEBI |
CHEBI:53770 ![]() |
ChEMBL | CHEMBL2104054 |
Chemical data | |
Formula | C19H22N2OS |
Molar mass | 326.456 g/mol |
| |
| |
(verify) |
Aceprometazine (INN) is a phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.